About Symmetry Medical
Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Exchange: NYSE
- Symbol: SMA
- CUSIP: 87154620
Key Metrics:
- Previous Close: $0.00
- 50 Day Moving Average: $716
- 200 Day Moving Average: $677
- Trailing P/E Ratio: N/A
- P/E Growth: 0
- Market Cap: $N/A
Additional Links:
Companies Related to Symmetry Medical:
Consensus Ratings for Symmetry Medical (NYSE:SMA) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Symmetry Medical (NYSE:SMA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Symmetry Medical (NYSE:SMA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2014 | Q3 | $0.15 | $0.13 | $98.24 million | $95.90 million | View | Listen |  |
| 8/4/2014 | Q2 | $0.12 | $0.17 | $98.38 million | $101.30 million | View | Listen | |
| 5/1/2014 | Q1 | $0.09 | $0.09 | $99.10 million | $101.30 million | View | Listen | |
| 2/20/2014 | Q413 | $0.08 | $0.10 | $101.50 million | $101.20 million | View | Listen | |
| 10/31/2013 | Q313 | $0.07 | $0.08 | $99.05 million | $98.00 million | View | Listen | |
| 8/1/2013 | Q2 2013 | $0.08 | $0.09 | $99.01 million | $101.90 million | View | Listen | |
| 5/2/2013 | Q1 2013 | $0.15 | $0.06 | $106.04 million | $98.90 million | View | Listen | |
| 2/21/2013 | Q4 2012 | $0.18 | $0.17 | $107.81 million | $106.60 million | View | Listen | |
| 11/1/2012 | Q312 | $0.15 | $0.18 | $104.33 million | $100.90 million | View | N/A | |
| 8/2/2012 | | $0.13 | $0.14 | | | View | N/A | |
| 5/3/2012 | | $0.09 | $0.09 | | | View | N/A | |
| 2/23/2012 | | $0.04 | $0.01 | | | View | N/A | |
| 11/3/2011 | | $0.12 | $0.04 | | | View | N/A | |
| 8/4/2011 | | $0.14 | $0.16 | | | View | N/A | |
| 5/5/2011 | | $0.09 | $0.09 | | | View | N/A | |
| 2/24/2011 | | $0.15 | $0.14 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Symmetry Medical (NYSE:SMA)Current Year EPS Consensus Estimate: $-0.01 EPS
Dividend History for Symmetry Medical (NYSE:SMA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Symmetry Medical (NYSE:SMA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 4/3/2014 | Thomas Joseph Sullivan | CEO | Sell | 35,000 | $9.69 | $339,150.00 | |
| 3/5/2014 | Christopher Gene Cummins | SVP | Sell | 1,325 | $10.72 | $14,204.00 | |
| 2/27/2014 | Fred Hite | CFO | Sell | 29,310 | $10.45 | $306,289.50 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Symmetry Medical (NYSE:SMA)
Symmetry Medical (NYSE:SMA) Chart for Saturday, October, 1, 2016
